Kamal MA

General

Full name : Kamal Mohammad A. || Kamal Mohammad Amjad

First name : Mohammad A. || Mohammad Amjad

Mail : Dept of Biochemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451

Zip Code : 2006

City : Sydney

Country : Saudi Arabia

Email : mamjad@ksu.edu.sa

Phone :

Fax : 966 14675791

Website :

Directory :

References (64)

Title : In Silico and Ex Vivo Analyses of the Inhibitory Action of the Alzheimer Drug Posiphen and Primary Metabolites with Human Acetyl- and Butyrylcholinesterase Enzymes - Batool_2022_ACS.Pharmacol.Transl.Sci_5_70
Author(s) : Batool S , Furqan T , Hasan Mahmood MS , Tweedie D , Kamal MA , Greig NH
Ref : ACS Pharmacol Transl Sci , 5 :70 , 2022
PubMedID: 35178511

Title : Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) - Sivapalasingam_2021_J.Infect.Dis__
Author(s) : Sivapalasingam S , Saviolakis GA , Kulcsar K , Nakamura A , Conrad T , Hassanein M , Sumner G , Elango C , Kamal MA , Eng S , Kyratsous CA , Musser BJ , Frieman M , Kantrowitz J , Weinreich DM , Yancopoulos G , Stahl N , Lipsich L
Ref : J Infect Dis , : , 2021
PubMedID: 33507266

Title : Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review - Ahmad_2021_Curr.Neuropharmacol__
Author(s) : Ahmad SS , Khalid M , Kamal MA , Younis K
Ref : Curr Neuropharmacol , : , 2021
PubMedID: 33588732

Title : An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review - Karim_2020_Med.Chem_16_1007
Author(s) : Karim N , Khan H , Khan I , Guo O , Sobarzo-Sanchez E , Rastrelli L , Kamal MA
Ref : Med Chem , 16 :1007 , 2020
PubMedID: 31702507

Title : Ajmalicine and its Analogues against AChE and BuChE for the Management of Alzheimer's Disease: An In-silico study - Liu_2020_Curr.Pharm.Des__
Author(s) : Liu S , Dang M , Lei Y , Ahmad SS , Khalid M , Kamal MA , Chen L
Ref : Curr Pharm Des , : , 2020
PubMedID: 32264807

Title : A computational study of natural compounds from Bacopa monnieri in the treatment of Alzheimer's disease - Jamal_2020_Curr.Pharm.Des__
Author(s) : Jamal QMS , Siddiqui MU , Alharbi AH , Albejaidi F , Akhtar S , Alzohairy MA , Kamal MA , Kesari KK
Ref : Curr Pharm Des , : , 2020
PubMedID: 31894743

Title : Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development - Mueed_2018_Front.Neurosci_12_1017
Author(s) : Mueed Z , Tandon P , Maurya SK , Deval R , Kamal MA , Poddar NK
Ref : Front Neurosci , 12 :1017 , 2018
PubMedID: 30686983

Title : In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease - Iman_2018_CNS.Neurol.Disord.Drug.Targets_17_54
Author(s) : Iman K , Mirza MU , Mazhar N , Vanmeert M , Irshad I , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 17 :54 , 2018
PubMedID: 29336270

Title : Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects - Khan_2018_Biomed.Pharmacother_101_860
Author(s) : Khan H , Marya , Amin S , Kamal MA , Patel S
Ref : Biomed Pharmacother , 101 :860 , 2018
PubMedID: 29635895

Title : Elucidating Treatment of Alzheimer's Disease via Different Receptors - Ul Islam_2017_Curr.Top.Med.Chem_17_1400
Author(s) : Ul Islam B , Khan MS , Jabir NR , Kamal MA , Tabrez S
Ref : Curr Top Med Chem , 17 :1400 , 2017
PubMedID: 28049400

Title : Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses - Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820
Author(s) : Kamal MA , Shakil S , Nawaz MS , Yu QS , Tweedie D , Tan Y , Qu X , Greig NH
Ref : CNS Neurol Disord Drug Targets , 16 :820 , 2017
PubMedID: 28176640

Title : A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors - Shah_2017_Curr.Drug.Metab_18_96
Author(s) : Shah AA , Dar TA , Dar PA , Ganie SA , Kamal MA
Ref : Curr Drug Metab , 18 :96 , 2017
PubMedID: 27890007

Title : Pharmacological and Toxicological Profile of Harmane-beta-Carboline Alkaloid: Friend or Foe - Khan_2017_Curr.Drug.Metab_18_853
Author(s) : Khan H , Patel S , Kamal MA
Ref : Curr Drug Metab , 18 :853 , 2017
PubMedID: 28595532

Title : In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment - Ali_2016_CNS.Neurol.Disord.Drug.Targets_15_624
Author(s) : Ali B , Jamal QM , Shams S , Al-Wabel NA , Siddiqui MU , Alzohairy MA , Al Karaawi MA , Kesari KK , Mushtaq G , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 15 :624 , 2016
PubMedID: 26996169

Title : Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease - Ahmad_2014_CNS.Neurol.Disord.Drug.Targets_13_1315
Author(s) : Ahmad MZ , Ahmad J , Amin S , Rahman M , Anwar M , Mallick N , Ahmad FJ , Rahman Z , Kamal MA , Akhter S
Ref : CNS Neurol Disord Drug Targets , 13 :1315 , 2014
PubMedID: 25345516

Title : Molecular interaction of acetylcholinesterase with carnosic acid derivatives: a neuroinformatics study - Merad_2014_CNS.Neurol.Disord.Drug.Targets_13_440
Author(s) : Merad M , Soufi W , Ghalem S , Boukli F , Baig MH , Ahmad K , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :440 , 2014
PubMedID: 24059305

Title : A neuroinformatics study describing molecular interaction of Cisplatin with acetylcholinesterase: a plausible cause for anticancer drug induced neurotoxicity - Baig_2014_CNS.Neurol.Disord.Drug.Targets_13_265
Author(s) : Baig MH , Rizvi SM , Shakil S , Kamal MA , Khan S
Ref : CNS Neurol Disord Drug Targets , 13 :265 , 2014
PubMedID: 24059317

Title : Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus - Mushtaq_2014_CNS.Neurol.Disord.Drug.Targets_13_1432
Author(s) : Mushtaq G , Greig NH , Khan JA , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :1432 , 2014
PubMedID: 25345511

Title : Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies - Dai_2014_CNS.Neurol.Disord.Drug.Targets_13_271
Author(s) : Dai Y , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :271 , 2014
PubMedID: 24059324

Title : Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-beta Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway - Reale_2014_Curr.Alzheimer.Res_11_608
Author(s) : Reale M , Di Nicola M , Velluto L , D'Angelo C , Costantini E , Lahiri DK , Kamal MA , Yu QS , Greig NH
Ref : Curr Alzheimer Res , 11 :608 , 2014
PubMedID: 24359497

Title : Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study - Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447
Author(s) : Rizvi SM , Shakil S , Biswas D , Shaikh S , Bagga P , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :447 , 2014
PubMedID: 24059302

Title : Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452
Author(s) : Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Tabrez S , Akhtar S , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :452 , 2014
PubMedID: 24059300

Title : Linking Alzheimer's Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation - Kamal_2014_CNS.Neurol.Disord.Drug.Targets_13_338
Author(s) : Kamal MA , Priyamvada S , Anbazhagan AN , Jabir NR , Tabrez S , Greig NH
Ref : CNS Neurol Disord Drug Targets , 13 :338 , 2014
PubMedID: 24074448

Title : Current acetylcholinesterase-inhibitors: a neuroinformatics perspective - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391
Author(s) : Shaikh S , Verma A , Siddiqui S , Ahmad SS , Rizvi SM , Shakil S , Biswas D , Singh D , Siddiqui MH , Tabrez S , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :391 , 2014
PubMedID: 24059296

Title : Sub-chronic exposure of non-observable adverse effect dose of terbufos sulfone: neuroinflammation in diabetic and non-diabetic rats - Nurulain_2014_CNS.Neurol.Disord.Drug.Targets_13_1397
Author(s) : Nurulain SM , Adeghate E , Sheikh A , Yasin J , Kamal MA , Sharma C , Adem A , Ojha S
Ref : CNS Neurol Disord Drug Targets , 13 :1397 , 2014
PubMedID: 25345510

Title : Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach - Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
Author(s) : Alam A , Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Imran M , Haneef M , Abuzenadah AM , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :487 , 2014
PubMedID: 24059299

Title : Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, alpha -Synuclein Synthesis, Interleukin-1beta Release, and Cholinergic Action - Yu_2013_Antiinflamm.Antiallergy.Agents.Med.Chem_12_117
Author(s) : Yu QS , Reale M , Kamal MA , Holloway HW , Luo W , Sambamurti K , Ray B , Lahiri DK , Rogers JT , Greig NH
Ref : Antiinflamm Antiallergy Agents Med Chem , 12 :117 , 2013
PubMedID: 23360256

Title : Molecular interaction of the antineoplastic drug, methotrexate with human brain acetylcholinesterase: a docking study - Shakil_2012_CNS.Neurol.Disord.Drug.Targets_11_142
Author(s) : Shakil S , Kamal MA , Tabrez S , Abuzenadah AM , Chaudhary AG , Damanhouri GA
Ref : CNS Neurol Disord Drug Targets , 11 :142 , 2012
PubMedID: 22483282

Title : Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study - Shakil_2011_CNS.Neurol.Disord.Drug.Targets_10_845
Author(s) : Shakil S , Khan R , Tabrez S , Alam Q , Jabir NR , Sulaiman MI , Greig NH , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 10 :845 , 2011
PubMedID: 21999734

Title : Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach - Al-Jafari_2011_CNS.Neurol.Disord.Drug.Targets_10_928
Author(s) : Al-Jafari AA , Shakil S , Reale M , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 10 :928 , 2011
PubMedID: 22229321

Title : Multiple approaches to analyse the data for rat brain acetylcholinesterase inhibition by cyclophosphamide - Kamal_2010_Neurochem.Res_35_1501
Author(s) : Kamal MA , Reale M , Al-Jafari AA
Ref : Neurochem Res , 35 :1501 , 2010
PubMedID: 20652634

Title : Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer disease - Kamal_2009_Neurochem.Res_34_2163
Author(s) : Kamal MA , Tan Y , Seale JP , Qu X
Ref : Neurochem Res , 34 :2163 , 2009
PubMedID: 19504347

Title : Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis - Kamal_2008_J.Neural.Transm.(Vienna)_115_889
Author(s) : Kamal MA , Qu X , Yu QS , Tweedie D , Holloway HW , Li Y , Tan Y , Greig NH
Ref : J Neural Transm (Vienna) , 115 :889 , 2008
PubMedID: 18235987

Title : Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine - Kamal_2008_Neurochem.Res_33_745
Author(s) : Kamal MA , Klein P , Luo W , Li Y , Holloway HW , Tweedie D , Greig NH
Ref : Neurochem Res , 33 :745 , 2008
PubMedID: 17985237

Title : Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine - Kamal_2006_Biochim.Biophys.Acta_1760_200
Author(s) : Kamal MA , Al-Jafari AA , Yu QS , Greig NH
Ref : Biochimica & Biophysica Acta , 1760 :200 , 2006
PubMedID: 16309845

Title : Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine - Kamal_2006_J.Alzheimers.Dis_10_43
Author(s) : Kamal MA , Klein P , Yu QS , Tweedie D , Li Y , Holloway HW , Greig NH
Ref : J Alzheimers Dis , 10 :43 , 2006
PubMedID: 16988481

Title : Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine - Kamal_2000_Biochem.Pharmacol_60_561
Author(s) : Kamal MA , Greig NH , Alhomida AS , Al-Jafari AA
Ref : Biochemical Pharmacology , 60 :561 , 2000
PubMedID: 10874131

Title : Kinetic analysis of the toxicological effect of tacrine (Cognex) on human retinal acetylcholinesterase activity - Alhomida_2000_Toxicology_147_33
Author(s) : Alhomida AS , Al-Rajhi AA , Kamal MA , Al-Jafari AA
Ref : Toxicology , 147 :33 , 2000
PubMedID: 10837930

Title : Thermodynamic analysis of human retinal acetylcholinesterase inhibition using an anti-Alzheimer's drug, tacrine, through the development of a dual substrate and temperature model - Kamal_2000_Proc.Natl.Sci.Counc.Repub.China.B_24_108
Author(s) : Kamal MA , Alhomida AS , Al-Rajhi AA , Al-Jafari AA
Ref : Proc Natl Sci Counc Repub China B , 24 :108 , 2000
PubMedID: 10943943

Title : Dual substrate model for novel approach towards a kinetic study of acetylcholinesterase inhibition by diazinon - Kamal_2000_J.Enzyme.Inhib_15_201
Author(s) : Kamal MA , Al-Jafari AA
Ref : J Enzyme Inhib , 15 :201 , 2000
PubMedID: 10938544

Title : Kinetic constants for the inhibition of camel retinal acetylcholinesterase by the carbamate insecticide lannate - Kamal_1999_J.Biochem.Mol.Toxicol_13_41
Author(s) : Kamal MA , Al-Jafari AA
Ref : J Biochem Mol Toxicol , 13 :41 , 1999
PubMedID: 9890446

Title : Human erythrocyte acetylcholinesterase inhibition by cis- diamminediaquaplatinum (II): a novel kinetic approach - Kamal_1999_Cancer.Lett_138_115
Author(s) : Kamal MA , Nasim FH , Al-Jafari AA
Ref : Cancer Letters , 138 :115 , 1999
PubMedID: 10378782

Title : Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: kinetic characterization - al-Jafari_1998_J.Biochem.Mol.Toxicol_12_245
Author(s) : Al-Jafari AA , Kamal MA , Alhomida AS
Ref : J Biochem Mol Toxicol , 12 :245 , 1998
PubMedID: 9580877

Title : Acetylcholinesterase inhibition by diazinon: A dual substrate model for kinetic study -
Author(s) : Kamal MA , Al-Jafari AA
Ref : Journal de Physiologie (Paris) , 92 :444 , 1998
PubMedID:

Title : Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine - al-Jafari_1998_Biochem.Biophys.Res.Commun_248_180
Author(s) : Al-Jafari AA , Kamal MA , Greig NH , Alhomida AS , Perry ER
Ref : Biochemical & Biophysical Research Communications , 248 :180 , 1998
PubMedID: 9675107

Title : Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin - Al-Jafari_1998_Cancer.Lett_128_79
Author(s) : Al-Jafari AA , al-Khwyter F , Kamal MA
Ref : Cancer Letters , 128 :79 , 1998
PubMedID: 9652796

Title : Sensitivity of bovine retinal acetylcholinesterase to phenserine: A derivative of physostigmine -
Author(s) : Al-Jafari AA , Kamal MA , Greig NH
Ref : Journal de Physiologie (Paris) , 92 :402 , 1998
PubMedID:

Title : On the inhibition of camel retina acetylcholinesterase activity by cycloheximide in vitro - al-Jafari_1998_Cell.Biol.Toxicol_14_167
Author(s) : Al-Jafari AA , Kamal MA , Alhomida AS
Ref : Cell Biol Toxicol , 14 :167 , 1998
PubMedID: 9689490

Title : Evaluation of the nature of camel retinal acetylcholinesterase: inhibition by hexamethonium - Alhomida_1997_J.Enzyme.Inhib_12_303
Author(s) : Alhomida AS , Kamal MA , Al-Jafari AA
Ref : J Enzyme Inhib , 12 :303 , 1997
PubMedID: 9502051

Title : Dual temperature model for the estimation of energetics parameters for acetylcholinesterase inhibition by cyclophosphamide - Kamal_1997_Biochem.Mol.Biol.Int_43_571
Author(s) : Kamal MA
Ref : Biochemistry & Molecular Biology International , 43 :571 , 1997
PubMedID: 9352076

Title : Effect of sevin on kinetic parameters of camel retina acetylcholinesterase - Kamal_1997_Biochem.Mol.Biol.Int_42_235
Author(s) : Kamal MA
Ref : Biochemistry & Molecular Biology International , 42 :235 , 1997
PubMedID: 9238521

Title : Estimation and correlation of IC50 for the inhibition of human erythrocyte acetylcholinesterase by cis-diamminediaquaplatinum (II) - Kamal_1997_Anticancer.Res_17_4483
Author(s) : Kamal MA , Bakkar MS , Al-Jafari AA
Ref : Anticancer Research , 17 :4483 , 1997
PubMedID: 9494555

Title : Kinetics of human erythrocyte acetylcholinesterase inhibition by cis- diamminediaquaplatinum (II) - Kamal_1997_Anticancer.Res_17_4487
Author(s) : Kamal MA
Ref : Anticancer Research , 17 :4487 , 1997
PubMedID: 9494556

Title : Investigation of the effect of lannate on kinetic parameters of acetylcholinesterase: slightly concave mixed-type of inhibition system - Kamal_1997_Biochem.Mol.Biol.Int_43_1183
Author(s) : Kamal MA
Ref : Biochemistry & Molecular Biology International , 43 :1183 , 1997
PubMedID: 9442915

Title : Purification and characterization of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom - Duhaiman_1996_Biochimie_78_46
Author(s) : Duhaiman AS , Alhomida AS , Rabbani N , Kamal MA , Al-Jafari AA
Ref : Biochimie , 78 :46 , 1996
PubMedID: 8725010

Title : In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate - Kamal_1996_Mol.Cell.Biochem_159_47
Author(s) : Kamal MA , Nasim FH , Al-Jafari AA
Ref : Molecular & Cellular Biochemistry , 159 :47 , 1996
PubMedID: 8813709

Title : The inhibitory effect of cyclophosphamide on camel retina acetylcholinesterase activity - al-Khwyter_1996_Toxicol.Lett_87_69
Author(s) : al-Khwyter F , Kamal MA , Al-Jafari AA
Ref : Toxicology Letters , 87 :69 , 1996
PubMedID: 8914613

Title : The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase - Kamal_1996_Prep.Biochem.Biotechnol_26_105
Author(s) : Kamal MA , Al-Jafari AA
Ref : Preparative Biochemistry & Biotechnology , 26 :105 , 1996
PubMedID: 8784921

Title : Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase - Al-Jafari_1996_Biochem_38_577
Author(s) : Al-Jafari AA , Kamal MA
Ref : Biochemistry & Molecular Biology International , 38 :577 , 1996
PubMedID: 8829618

Title : Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase - Kamal_1996_Biochem_39_293
Author(s) : Kamal MA , Nasim FH , Al-Jafari AA
Ref : Biochemistry & Molecular Biology International , 39 :293 , 1996
PubMedID: 8799456

Title : Acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom: optimization and kinetics study - Al-Jafari_1995_Mol.Cell.Biochem_151_21
Author(s) : Al-Jafari AA , Kamal MA , Duhaiman AS , Alhomida AS
Ref : Molecular & Cellular Biochemistry , 151 :21 , 1995
PubMedID: 8584009

Title : Inhibition of human acetylcholinesterase by cyclophosphamide - Al-Jafari_1995_Toxicology_96_1
Author(s) : Al-Jafari AA , Duhaiman AS , Kamal MA
Ref : Toxicology , 96 :1 , 1995
PubMedID: 7863507

Title : The mode of inhibition of human erythrocyte membrane-bound acetylcholinesterase by cisplatin in vitro - Al-Jafari_1995_J.Enzyme.Inhib_8_281
Author(s) : Al-Jafari AA , Kamal MA , Duhaiman AS
Ref : J Enzyme Inhib , 8 :281 , 1995
PubMedID: 7542325

Title : The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase - Al-Jafari_1994_Cell.Biochem.Func_12_29
Author(s) : Al-Jafari AA , Kamal MA
Ref : Cell Biochemistry & Function , 12 :29 , 1994
PubMedID: 8168228